Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jie Zhou, Jing Hou, Jun Rao, Conghui Zhou, Yunlong Liu & Wenxi Gao. (2020) Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin. International Journal of Nanomedicine 15, pages 4639-4657.
Read now
Read now
Carla Souza, Diogo Silva Pellosi & Antonio Claudio Tedesco. (2019) Prodrugs for targeted cancer therapy. Expert Review of Anticancer Therapy 19:6, pages 483-502.
Read now
Read now
Marie-Paule Kieny. (2018) Lessons learned from Ebola Vaccine R&D during a public health emergency. Human Vaccines & Immunotherapeutics 14:9, pages 2114-2115.
Read now
Read now
Articles from other publishers (26)
Patrick T. Paine, Ada Nguyen & Alejandro Ocampo. (2023) Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology. Aging Cell.
Crossref
Crossref
Fatemeh Moradbeygi, Younes Ghasemi, Ahmad Reza Farmani & Shiva Hemmati. (2023) Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy. Biomedicine & Pharmacotherapy 166, pages 115292.
Crossref
Crossref
J. Peter Lee, Broderick C. Corless, Thomas J. Gardner, David A. Scheinberg & Derek S. Tan. (2023)
Development of a
p
-Hydroxybenzyl-Alcohol-Linked Glutamate Prodrug for Activation by
Pseudomonas
Carboxypeptidase G2
. Organic Letters 25:34, pages 6295-6299.
Crossref
Crossref
Vasco Lucas, Cláudia Cavadas & Célia Alexandra Aveleira. (2023) Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies. Pharmacological Reviews 75:4, pages 675-713.
Crossref
Crossref
Broderick C. Corless, Raphael Geißen, Nicholas A. Prescott, Yael David, David A. Scheinberg & Derek S. Tan. (2023) Chemoenzymatic Synthesis of Novel Cytotoxic Epoxyketones Using the Eponemycin Biosynthetic Enzyme EpnF. ACS Chemical Biology 18:6, pages 1360-1367.
Crossref
Crossref
Miguel Arroyo, Isabel de la Mata, Carlos Barreiro, José Luis García & José Luis Barredo. 2023. Biotechnology of Microbial Enzymes. Biotechnology of Microbial Enzymes
341
373
.
Rosa Vincent & Tal Danino. (2021) CAR-T cells SEAK help from enzymes. Nature Chemical Biology 18:2, pages 122-123.
Crossref
Crossref
Thomas J. Gardner, J. Peter Lee, Christopher M. Bourne, Dinali Wijewarnasuriya, Nihar Kinarivala, Keifer G. Kurtz, Broderick C. Corless, Megan M. Dacek, Aaron Y. Chang, George Mo, Kha M. Nguyen, Renier J. Brentjens, Derek S. Tan & David A. Scheinberg. (2021) Engineering CAR-T cells to activate small-molecule drugs in situ. Nature Chemical Biology 18:2, pages 216-225.
Crossref
Crossref
Bao Le‐Vinh, Zeynep Burcu Akkuş‐Dağdeviren, Nguyet‐Minh Nguyen Le, Imran Nazir & Andreas Bernkop‐Schnürch. (2022) Alkaline Phosphatase: A Reliable Endogenous Partner for Drug Delivery and Diagnostics. Advanced Therapeutics 5:2.
Crossref
Crossref
Feray Kockar, Esra Tokay & Nelin Hacioglu. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases
239
271
.
Aliyah B. Silver, Elissa K. Leonard, Joseph R. Gould & Jamie B. Spangler. (2021) Engineered antibody fusion proteins for targeted disease therapy. Trends in Pharmacological Sciences 42:12, pages 1064-1081.
Crossref
Crossref
Suckwon Lee, Ellen Y. Wang, Alexandra B. Steinberg, Chaska C. Walton, Shankar J. Chinta & Julie K. Andersen. (2021) A guide to senolytic intervention in neurodegenerative disease. Mechanisms of Ageing and Development 200, pages 111585.
Crossref
Crossref
Kuan-Ju Chen, Adam J. Plaunt, Franziska G. Leifer, Jeong Yeon Kang & David Cipolla. (2021) Recent advances in prodrug-based nanoparticle therapeutics. European Journal of Pharmaceutics and Biopharmaceutics 165, pages 219-243.
Crossref
Crossref
Ignacio Rivero Berti, German A. Islan & Guillermo R. Castro. (2021) Enzymes and biopolymers. The opportunity for the smart design of molecular delivery systems. Bioresource Technology 322, pages 124546.
Crossref
Crossref
Mohammed S. Aldughaim, Fatimah Alsaffar & Michael D. Barker. (2021) Coupling of a Novel TIMP3 Peptide to Carboxypeptidase G2 for Pro-Drug Activation at the Tumour Site. Molecules 26:3, pages 625.
Crossref
Crossref
Layla Al-mansoori, Alanod D. Al Qahtani, Philip Elsinga & Sayed K. Goda. (2021) Production of Long-Acting CNGRC–CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment. Technology in Cancer Research & Treatment 20, pages 153303382110573.
Crossref
Crossref
Sara S Bashraheel, Alexander Domling & Sayed K Goda. (2020) Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine. Biomedicine & Pharmacotherapy 125, pages 110009.
Crossref
Crossref
Layla Al-mansoori, Sara S. Bashraheel, Alanod D. Al Qahtani, C. David O’Connor, Philip Elsinga & Sayed K. Goda. (2020)
In vitro
studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy
. Oncotarget 11:6, pages 619-633.
Crossref
Crossref
Shambojit Roy, Michael Brasino, Jonathan M. Beirne, Albert Harguindey, Douglas A. Chapnick, Xuedong Liu, Jennifer N. Cha & Andrew P. Goodwin. (2019) Enzymes Photo-Cross-Linked to Live Cell Receptors Retain Activity and EGFR Inhibition after Both Internalization and Recycling. Bioconjugate Chemistry 31:1, pages 104-112.
Crossref
Crossref
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov & Gary L. Gilliland. (2019) Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies 8:4, pages 55.
Crossref
Crossref
Jean Felix Mukerabigwi, Wei Yin, Zengshi Zha, Wendong Ke, Yuheng Wang, Weijian Chen, Abd Al-Wali Mohammed Mohammed Japir, Yi Wang & Zhishen Ge. (2019) Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy. Journal of Controlled Release 303, pages 209-222.
Crossref
Crossref
Alanod D. Al-Qahtani, Sara S. Bashraheel, Fatma B. Rashidi, C. David O’Connor, Atilio Reyes Romero, Alexander Domling & Sayed K. Goda. (2019) Production of “biobetter” variants of glucarpidase with enhanced enzyme activity. Biomedicine & Pharmacotherapy 112, pages 108725.
Crossref
Crossref
Andrey A. Tregubov, Petr I. Nikitin & Maxim P. Nikitin. (2018) Advanced Smart Nanomaterials with Integrated Logic-Gating and Biocomputing: Dawn of Theranostic Nanorobots. Chemical Reviews 118:20, pages 10294-10348.
Crossref
Crossref
Zuben E. Sauna, Daniel Lagassé, Joao Pedras-Vasconcelos, Basil Golding & Amy S. Rosenberg. (2018) Evaluating and Mitigating the Immunogenicity of Therapeutic Proteins. Trends in Biotechnology 36:10, pages 1068-1084.
Crossref
Crossref
Fatma B. Rashidi, Alanod D. AlQhatani, Sara S. Bashraheel, Shabnam Shaabani, Matthew R. Groves, Alexander Dömling & Sayed K. Goda. (2018) Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment. PLOS ONE 13:4, pages e0196254.
Crossref
Crossref
Surinder K. Sharma & Kenneth D. Bagshawe. (2017) Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations. Advanced Drug Delivery Reviews 118, pages 2-7.
Crossref
Crossref